Sleep-disordered breathing (SDB) is associated with an increased risk of cardiovascular events. Previous studies showed that severe SDB has a negative impact on myocardial salvage and progression of left ventricular dysfunction after acute myocardial infarction (AMI). This study investigated the frequency of SDB and the effects of SDB on left ventricular function after AMI. This retrospective study enrolled all patients with AMI who had undergone cardiorespiratory polygraphy for SDB diagnosis. The apnea-hypopnea index was used as a standard metric of SDB severity. SDB was classified as mild (apnea-hypopnea index >5 to <15 per h), moderate (≥15 to <30 per h) or severe (apnea-hypopnea index ≥30 per h). According to the majority of events, SDB was classified as predominant obstructive sleep apnea, central sleep apnea or mixed sleep apnea (mixed SDB). A total of 223 patients with AMI (112 with ST elevation and 111 without ST elevation; 63.2 AE 11.2 years, 82% male, left ventricular ejection fraction 49 AE 12%) were enrolled. SDB was present in 85.6%, and was moderate-to-severe in 63.2%; 40.8% had obstructive sleep apnea, 41.7% had central sleep apnea and 3.1% had mixed SDB. Left ventricular ejection fraction was lower in patients with AMI with severe SDB (45 AE 14%) versus those without SDB (57 AE 7%; P < 0.005). In addition, lower left ventricular ejection fraction (≤45%) was associated with increased frequency (apnea-hypopnea index ≥5 per h in 96%) and severity (apnea-hypopnea index ≥30 per h in 48%) of SDB in general and a higher percentage of central sleep apnea (57%) in particular. SDB is highly frequent in patients with AMI. SDB severity appeared to be linked to impaired left ventricular function, especially in patients with central sleep apnea.
IN TROD UCTI ON
Coronary artery disease (CAD) is the most frequent cause of death worldwide (Task Force et al., 2013) , and continues to be associated with ongoing high social and economic burden. Mortality rates associated with acute coronary syndrome are substantial, at 9.1% for the period between admission to hospital and 6-month follow-up (Fox et al., 2006) .
Timing is crucial when treating acute coronary events, and early intervention plays a pivotal role in salvaging as much myocardium as possible. Since the introduction and widespread use of revascularization procedures and guidelinebased pharmacological therapy (Hamm et al., 2011; Steg et al., 2012) , the long-term prognosis for patients with acute coronary syndromes has improved markedly, but new therapeutic approaches are needed (Fox et al., 2010) . One current approach to improving outcomes in coronary patients is to focus on the important role of co-morbidities, such as sleep-disordered breathing (SDB). There is therefore a growing interest in the associations between SDB and acute myocardial infarction (AMI) based on the strong epidemiological data linking SDB and AMI (BaHammam et al., 2005; Buchner et al., 2012; Hetzenecker et al., 2013; Hung et al., 1990; Ludka et al., 2014; Mehra et al., 2006; Schiza et al., 2012) .
There are two main types of SDB in patients with CAD: obstructive sleep apnea (OSA) and central sleep apnea (CSA), with or without Cheyne-Stokes respiration (CSR). OSA is characterized by upper airway obstruction causing a cessation of airflow while breathing effort is increased. In CSA, cessation of airflow is a result of central respiratory dysregulation (Linz et al., 2015) .
Sleep-disordered breathing results in recurrent intermittent hypoxia and sympathetic activation, which induce myocardial oxidative stress and favour ischaemic injury (Joyeux-Faure et al., 2005; Ramond et al., 2013) , reduce myocardial salvage, increase infarct size and limit recovery of left ventricular function (Buchner et al., 2014; Nakashima et al., 2006) . Chronic inflammation and endothelial dysfunction have been documented in patients with SDB, which contribute to the progression of atherosclerosis, adverse cardiac remodelling and arrhythmogenesis (Fox et al., 2016a) . This means that patients with SDB are at increased risk of experiencing AMI and sudden cardiac death (Gami et al., 2005) . Although the association between SDB and CAD is well known, published clinical data are limited because previous studies mostly had small sample sizes or did not differentiate between different SDB types. In addition to that therapy in SDB and CAD is frequently discussed, as the RICCADSA trial of 244 patients with CAD did not show a reduction of cardiovascular incidents in routine continuous positive airway pressure (CPAP) use, but showed the benefit of CPAP after adjustment for baseline co-morbidities and compliance (Peker et al., 2016) . This study investigated the relationship between SDB and AMI by determining the presence of SDB, different SDB types, SDB severities, and obtaining left ventricular function in patients with AMI. We hypothesized that SDB would be a common co-morbidity in patients with AMI and may have a negative influence on left ventricular function after AMI.
MATERI ALS AND METHODS
In this single-centre, cross-sectional, observational analysis, data for all eligible patients who had undergone routine clinical treatment in the cardiology department from May 2005 to June 2014 were extracted from the hospital information system, and each patient of the total 3427 identified patients was individually reviewed to determine whether they met all the inclusion and exclusion criteria. Inclusion criteria were a diagnosis of AMI [ST-elevation myocardial infarction (STEMI) or non-ST-elevation myocardial infarction (NSTEMI)] as universally defined (Thygesen et al., 2012) . Further assessment with polygraphy (PG), if the patients were willing to undergo PG, and documented echocardiographic parameters within 3 days of ACS (acute coronary syndrome) were performed. Exclusion criteria were acute cardiac shock, haemodynamic instability (e.g. requirement for catecholamine therapy), known treated or untreated sleep apnea, incomplete clinical data and documentation, or PG recordings that could not be analysed. Further exclusions were concurrent disease with potential to falsify PG recordings, such as infections or sedation medications.
In accordance with current guidelines, AMI was defined as acute myocardial ischaemia with a rise in cardiac biomarker values (cardiac troponin I) accompanied by symptoms of ischaemia, new persistent electrocardiogram changes (ST-T changes, new left bundle branch block or development of pathological Q-waves), imaging evidence of new loss of myocardial viability or identification of an intracoronary thrombus (Hamm et al., 2011; Steg et al., 2012) . All patients were treated for ACS either conservatively, with percutaneous coronary intervention (PCI), or with coronary artery bypass graft.
All patients underwent an overnight sleep study using unattended cardiorespiratory PG. The following parameters were recorded continuously: nasal airflow measured by nasal pressure, chest and abdominal effort, pulse oximetry, snoring and body position. Only temporary loss of one channel, except for nasal airflow, was tolerated. All PG recordings were independently and blindly analysed according to American Academy of Sleep Medicine (AASM) scoring recommendations (Berry et al., 2012) . Apnea was defined as a decrease in airflow to <10% of the recent average for ≥10 s (without any breathing efforts for CSA, and with typical thoracic and abdominal efforts for OSA). Hypopnea was defined as a ≥30% decrease in airflow together with a ≥3% fall in oxygen saturation. The definition used for the oxygen desaturation index (ODI) was the number of arterial oxygen desaturations of ≥3% per h of sleep time.
Sleep-disordered breathing severity was classified using the apnea-hypopnea index (AHI), defined as the number of apneas and hypopneas per hour of sleep time. An AHI ≥ 5 per h to <15 per h was defined as mild SDB, ≥15 per h to <30 per h as moderate SDB, and ≥30 per h as severe SDB. In addition, SDB was classified as predominant OSA, CSA or mixed SDB, based on the most common type of events, patients with more than 50% obstructive respiratory events were classified as obstructive and patients with more than 50% central respiratory events were classified as central according to AASM rules. Left ventricular ejection fraction (LVEF) was evaluated during hospitalization and after revascularization, and was determined with two-dimensional echocardiography using apical four-chamber view and Simpson's method.
This study conforms to the guiding principles of the Declaration of Helsinki, and it has been approved by our institutional ethics committee, Reg.-Nr. 40/2014.
Statistical methods
Statistical analysis was conducted with IBM SPSS 22, IBM, Armonk, NY, USA, for Mac, Apple, Cupertino, CA, USA. A Pvalue of <0.05 was defined to be statistically significant. Data are expressed as number of patients and/or percentages for discrete variables, and as means AE standard deviation for continuous variables. Comparisons between ACS groups were performed by Student's t-test, and P-values as well as continuous variables were compared using analysis of variance (ANOVA). Categorical comparisons were made using
Chi-square analysis, and non-parametric inferential statistical analyses were performed using Mann-Whitney U-test, Wilcoxon rank sum test and Spearman's rank correlation coefficient. Multivariable linear regression models were calculated, adjusting for important factors, to investigate the influence of SDB; combinations and interactions of these predictors were also investigated, and adjustment factors were selected based on stepwise backward selection, using a likelihood ratio test with significance level 0.05.
RESUL TS
A total of 223 patients were eligible for inclusion in the study. Patient flow through the study is shown in Fig. 1 , and baseline demographic and clinical characteristics of the total study population and subgroups based on the type of SDB and type of AMI are reported in Table 1 . All diagnostics for this study were obtained within 3 days after ACS, while there was no influence on the study results which day of the first 3 days was chosen for investigation. All patients underwent coronary angiography, and the majority (>75%) were treated with PCI. NSTEMI patients were older than those with STEMI (65 AE 11 years versus 62 AE 11 years, respectively), and were also more likely to have additional cardiovascular risk factors and to have experienced a previous cardiovascular event. Left ventricular function was worse in patients with CSA compared with OSA. Sleep characteristics recorded during PG are shown in Table 2 .
Frequency of SDB in patients with AMI
The frequency of SDB of any severity was high (85.6%), and moderate-to-severe SDB was documented in almost twothirds of patients (63.2%); only 14.3% of patients with AMI had no SDB (AHI < 5 per h; Fig. 2 ). Predominant OSA was present in 40.8% of patients and 41.7% had predominant CSA. Based on PG findings, patients with CSA versus OSA had a significantly higher mean AHI (35 per h versus 23 per h) and ODI (30 per h versus 21 per h). Mean desaturation was also higher in patients with CSA, but the lowest oxygen saturation during the night was measured in patients with OSA.
Sleep-disordered breathing severity was mild in 22.4% of patients, moderate-to-severe in 28.7% and severe in 34.5% (Fig. 2 ). There were no differences between STEMI and NSTEMI patients with respect to SDB frequency, type or severity.
Association between SDB and left ventricular function after AMI
The presence of co-morbid SDB was strongly associated with left ventricular function after AMI ( Fig. 3 ; Table 3 ). There was a negative correlation between SDB severity and the degree of left ventricular function impairment (correlation coefficient À0.58, P < 0.01). In addition, patients with more impaired left ventricular function (lower LVEF) more often presented with CSA (correlation coefficient À0.63, P < 0.01).
The association between left ventricular function and SDB was particularly apparent in the subgroup of patients with an LVEF of <45%. Compared with the entire cohort, the frequency of SDB was increased in these patients (96.2% versus 85.6%), and the percentage of CSA was higher (57% versus 42%). Furthermore, 48% of these patients had severe SDB. Correspondingly, patients with better preserved LVEF (>45%) had a lower frequency of SDB (80%), a higher percentage of OSA (46%), and more often had mild (29%) or moderate-to-severe (24%) SDB. The LVEF was not significantly affected by patient characteristics such as age, gender or body mass index, but with SDB/CSA (Table 3 ). There was Values are mean AE standard deviation or number of patients (%). CSA, central sleep apnea; LVEF, left ventricular ejection fraction; NSTEMI, non-ST-elevation myocardial infarction; OSA, obstructive sleep apnea; PCI, percutaneous coronary intervention; SDB, sleep-diordered breathing; STEMI, ST-elevation myocardial infarction.
ª 2017 European Sleep Research Society a significant difference in cardiac dimensions (including left atrial diameter and left ventricular end-diastolic diameter) in patients with severe SDB compared with those who had no SDB (P < 0.005). In particular, patients with CSA had greater left atrial size than those with OSA or no SDB.
DI SCUSSION
The frequency of SDB in this group of patients with AMI was unexpectedly high, at 86%, for the number of patients that were willing and able to undergo PG recording in the setting of our study. Approximately equal proportions of patients had OSA and CSA (41% and 42%, respectively), while the number of patients with mixed apnea was small (3%). More than one-third of patients (35%) had severe sleep apnea (AHI > 30 per h), and there was a significant correlation between impaired left ventricular function and SDB in general and with CSA in particular.
To date, only a few studies have reported a high prevalence of SDB in patients with AMI. Similar to our results, an investigation using cardiorespiratory PG documented an SDB frequency of 65.7% (AHI > 15 per h) in 105 patients with AMI and primary PCI, with 43% having severe SDB, although this study did not differentiate between the different forms of SDB (Lee et al., 2009) . Mehra et al. (2006) reported an SDB prevalence of 66.4% (AHI > 10 per h), but the vast majority of the 104 patients studied had stable or unstable angina (85.5%) rather than AMI. When only patients with AMI were considered, the frequency of SDB was 73.2%, similar to the current data.
In a recent study including 607 patients with AMI, SDB (AHI ≥ 5 per h) was detected in 65.7%, but most patients had only mild SDB and only 12.7% had severe SDB (Ludka et al., 2014) . Once again, this study used a simple screening device and could not differentiate between SDB types. In a number of smaller studies (n = 40-52), the reported frequency of SDB (defined as an AHI of >10 per h or >15 per h) was lower, at 55-62% (BaHammam et al., 2005; Buchner et al., 2012; Hetzenecker et al., 2013; Schiza et al., 2012) . The high number of patients with SDB identified in our study, with a proportion of 50% with moderate to severe SDB, is in accordance with previous large investigations (Arzt et al., 2016; Oldenburg et al., 2007) where the same risk factors for SDB, for example, male sex, age and body mass index, are described and identified as in our study. In addition to that there are large studies that describe similar high SDB prevalence, especially in cardiovascular patients and after ACS, similar to our current findings (Fox et al., 2016b) .
The majority of patients affected with AMI and SDB are male, with our study results being in line with previous findings, as the majority of patients are male (Masoudi et al., 2013) and the majority of patients having SDB are male (Arzt et al., 2016; Fox et al., 2016b; Oldenburg et al., 2007) . Multiple factors come into play for this fact, such as different lifestyles, but also hormonal and genetic factors are under current discussion (Arzt et al., 2016) . Discrepancies between the SDB frequency and severity found in different studies may have been due to higher sensitivity and specificity of a more sophisticated cardiorespiratory PG device compared with simple screening devices, or to differences in the timing of the sleep study, as well as use of different definitions of SDB and scoring recommendations. In addition, there were disparities between different study populations with respect to co-morbidities and risk factors, making direct comparison difficult (Punjabi, 2008) .
Interestingly, in this study, we found a strong association between the presence of SDB and left ventricular function during early recovery after AMI revascularization. Very few previous studies have investigated the impact of SDB during the acute and chronic phase after myocardial infarction. In a rat model, sleep apnea-induced recurrent intermittent hypoxia induced myocardial oxidative stress and made the heart more vulnerable to ischaemic injury, resulting in increased myocardial infarct size (Joyeux-Faure et al., 2005; Ramond et al., 2013) .
To determine the impact of SDB on recovery of left ventricular function after AMI, Buchner et al. (2014) used cardiac magnetic resonance imaging to examine 56 patients shortly after PCI and 3 months later. They reported that SDB was an independent predictor of expanded infarct size and reduced myocardial salvage during the chronic phase after AMI; patients with SDB had a significantly lower LVEF and enlarged end-systolic and end-diastolic volumes. Data from another study also suggest that OSA causes less recovery of left ventricular function after AMI (Nakashima et al., 2006) . LVEF was evaluated using echocardiography shortly after PCI and after 3 weeks. Consistent with our data, the OSA group (37 patients) had a significantly higher LVEF, with a link to SDB severity.
The abovementioned studies mostly had small sample sizes and did not differentiate between the different types of SDB, meaning that existing scientific literature on associations between AMI and CSA is scarce. CSA prevalence has only been reported in two studies, at rates of 40 and 50% (BaHammam et al., 2005; Hetzenecker et al., 2013) . This is similar to the rate of CSA reported in our study population. Nevertheless, we conducted a cross-sectional study and our findings do not allow drawing conclusions about causality between SDB/CSA and LVEF. Both directions of influence are possible as SDB/CSA may negatively influence LVEF as recent large studies have identified (Arzt et al., 2016) , but worse LVEF may promote CSA on the other hand, as worse LVEF is associated with changes in SDB cycles as shown before (Basic et al., 2016) .
In patients with heart failure, the prevalence of CSA depends on systolic and/or diastolic cardiac function and appears to be a marker of heart failure severity (Oldenburg et al., 2007) . A similar connection was documented for CSA in our population of patients with AMI. CSA was significantly associated with lower LVEF and increased SDB severity. Especially striking was the high prevalence of CSA in patients with a LVEF of ≤45% (56.8%). Moreover, mean left atrial size was significantly greater in patients with CSA compared with those who had OSA or no SDB. A previous study of heart failure patients with SDB (AHI ≤ 35 per h) showed that left atrial size was associated with augmented carbon dioxide (CO 2 ) chemosensitivity (Calvin et al., 2014) . Pulmonary congestion promotes J-receptor stretch, triggering hyperventilation with resulting reduction in CO 2 concentration below the apnoeic threshold, leading to the characteristic breathing pattern of CSR. Central sleep apnea as a co-morbidity has a negative influence on the prognosis of patients with AMI or chronic heart failure. Javaheri et al. (2007) identified the presence of CSA (AHI ≥ 5 per h) as an independent predictor of mortality in stable systolic heart failure patients (LVEF ≤ 45%); median survival of patients without CSA was twice as long as for those with CSA (90 months versus 45 months). Furthermore, there is evidence that OSA is an independent predictor of major adverse cardiac events after PCI (Loo et al., 2014; Yumino et al., 2007) .
The associations between SDB and negative outcomes in cardiac patients detailed above are likely to be explained by the various adverse effects of SDB, such as nocturnal desaturation with intermittent hypoxia, arousals caused by sympathetic activation, and negative intrathoracic pressure (Eckert et al., 2007; Javaheri et al., 2007) . In particular, nocturnal desaturations have been linked to worse outcomes in patients with chronic heart failure (Gellen et al., 2015) . In addition, the amount of time spent with oxygen saturation of <90% (T < 90%; hypoxia) has been identified as an independent predictor of all-cause-mortality in a large group of patients with heart failure and reduced LVEF. A T < 90% value of 22 min was identified as the cut-off level indicating that patients had an increased risk of mortality . Interestingly, in our population of patients with AMI, the mean T < 90% was 38 min. Based on these findings, administration of oxygen would seem to be a reasonable treatment approach. However, it has been clearly shown that routine oxygen application in patients with uncomplicated AMI may even increase cardiac injury, with patients receiving supplemental oxygen having an increased median infarct size at 6 months and significantly higher median peak creatine kinase levels (Stub et al., 2015) . Previous studies do suggest that effective treatment of OSA is associated with a significant reduction in cardiac mortality (Cassar et al., 2007) and non-fatal cardiovascular events (Marin et al., 2005) compared with untreated OSA patients. However, there is no evidence for a need to specifically treat CSA in this context. There is one ongoing multicentre, randomized, prospective controlled trial that is investigating whether treatment of SDB early after AMI has a beneficial effect on myocardial salvage and outcomes (TEAM ASV I study; NCT02093377).
Although the current study is the largest to date in its field, the retrospective nature of the investigation is an important limitation. The lack of prospective data collection could have introduced bias into the data because patients were excluded for lack of sufficient data or missing PG recordings. In addition, SDB screening with PG is standard procedure for all patients with CAD in our department, meaning that all patients are subject to routine SDB screening, irrespective of the presence or absence of symptoms or scores on screening questionnaires; only patients refusing PG are excluded. In addition, previous studies have shown that preselection through questionnaires or scoring medical history is not a feasible approach to identifying SDB patients with CAD (Capodanno et al., 2011) . All sleep studies were performed using PG, rather than polysomnography, which is the accepted gold standard for determining the presence and severity of SDB. Unattended PG can underestimate SDB severity because the total recording time might be longer than the total sleep time.
CONC LUSION
In the setting of AMI a high frequency of SDB was detected, and the presence of SDB was associated with impaired left ventricular function. Lower LVEF and higher left atrial size were associated with more severe SDB and a high percentage of CSA. SDB may have a negative impact on myocardial healing after AMI, resulting in less myocardial salvage and a worse prognosis. Consideration should be given for evaluation of all patients with AMI for SDB.
